Tofacitinib 59651-0685-30

Package NDC

59651-0685-30

Manufacturer: Aurobindo Pharma Limited
Dosage Form: Tablet, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: May 14, 2026
Listing Expires: December 31, 2027
Application: ANDA218462

Need to source Tofacitinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Tofacitinib Citrate	11 mg/1

Drug Class

Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]

Selected Package

59651-0685-30Selected

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-685-30)